Structure and activity studies of glycine receptor ligands: Part 6. The structure of ethyl-N-[(p-Cl-benzylidene)-4-oxo-2-imidazolidyl]glycinate hydrochloride as the basis for a model of the ligand-receptor interaction

Journal of Molecular Structure

Volumn 516, Issue 2-3, 2000, Pages 113-121

  Karolak Wojciechowska, J ^a   Mrozek, A ^a   Kiec Kononowicz K ^b  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Glycine receptor ligands; IsoStar; X ray structure

Indexed keywords

GLYCINE RECEPTOR ANTAGONIST; N [(4 CHLORO BENZYLIDENE ) 4 OXO 2 IMIDAZOLIDYL]GLYCINE ETHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; LIGAND BINDING; MOLECULAR INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

EID: 0034711796     PISSN: 00222860     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2860(99)00193-3     Document Type: Article

References (24)

1. The pharmacology of excitatory amino acids: a special report. Lodge D., Collingridge G.L. Trends in Pharmacological Science. 1991.
2. Kupferberg H.J. Epilepsia. 30 (Suppl. 1):1989;551.
3. Leeson P.D., Iversen L.L. J. Med. Chem. 37:1994;4053.
4. Leeson P.D., Carling R.W., Moore K.W., Moseley A.M., Smith J.D., Stevenson G.I., Chan T., Baker R., Foster A.C., Grimwood S., Kemp J.A., Marshall G.R., Hoogsteen K. J. Med. Chem. 35:1954;1992.
5. Leeson P.D., Carling R.W., Kulagowski J.J., Mawer I.M., Moore K.W., Moseley A.M., Smith J.D., Stevenson G.I., Williams B.J., Baker R., Foster A.C., Kemp J.A., Tricklebank M.D. Testa B., Kyburz E. Perspectives in Medicinal Chemistry. 1993;239.
6. Carling R.W., Leeson P.D., Moore K.W., Moyes C.R., Duncton M., Hudson M.L., Baker R., Foster A.C., Gromwood S., Kemp J.A., Marshall G.R., Tricklebank M.D., Saywell K.L. J. Med. Chem. 40:1997;754.
7. MacLeod A.M., Grimwood S., Barton C., Bristow L., Saywell K.L., Marshall G.R., Bak R.G. J. Med. Chem. 38:1995;2239-2243.
8. Fabis R.D., Capelli A.M., Conti N., Cugola A., Donati D., Feriani A., Gastaldi G., Gaviraghi G., Hewkin C.T., Micheli F., Missio A., Mugnaini M., Pecunioso A., Quaglia A.M., Ratti E., Rossi L., Tedesco G., Trist D.G., Reggiani A. J. Med. Chem. 40:1997;841-850.
9. Colotta V., Catarzi D., Varano F., Cecchi L., Filacchioni G., Galli A., Castagli C. Arch. Pharm. Med. Chem. 330:1997;129-134.
10. Balsamini C., Bedini A., Diamantini G., Spadoni G., Tontini A., Tarzia G. J. Med. Chem. 41:1998;808-820.
11. Kieć-Kononowicz K., Karolak-Wojciechowska J., Handzlik J. Acta Pol. Pharm. Drug Res. 55:1998;381.
12. Karolak-Wojciechowska J., Mrozek A., Ksiażek W., Kieć-Kononowicz K., Handzlik J. J. Mol. Struct. 447:1998;89-96.
13. Kieć-Kononowicz K., Karolak-Wojciechowska J. Arch. Pharm. (Weinheim). 328:1995;119.
14. K. Kieć-Kononowicz, J. Karolak-Wojciechowska, in preparation.
15. G.M. Sheldrick, SHELXTL PC™, Siemens Analytical X-Ray Instruments Inc., Madison, Wisconsin, USA 1990.
16. G.M. Sheldrick, SHELXL-93, A FORTRAN-77 Program for the Refinement of Crystal Structures from Diffaction Data, University of Göttingen, Germany 1993.
17. Grimwood S., Moseley A.M., Carling M.W., Leeson P.D., Foster A.C. Mol. Pharmacol. 41:1992;923.
18. MOPAC Program, Version 6, QCPE No. 455; Department of Chemistry, Indiana University, Bloomington, IN, 1990.
19. Allen F.H., Davies J., Galloy J.E., Johnson J.J., Kennard O., Macrae C.F., Mitchell E.M., Smith J.M., Watson D.G. J. Chem. Inf. Comput. Sci. 31:1991;187.
20. Bernstein F.C., Koetzle T.F., Williams G.J.B., Meyer E.F., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. J. Mol. Biol. 112:1977;535.
21. IsoStar Database.
22. Bruno J.I., Cole J.C., Lommerse J.P.M., Rowland R.S., Taylor R., Verdonk M. J. Comput.-Aided Mol. Design. 11:1997;525.
23. Kieć-Kononowicz K., Karolak-Wojciechowska J. Acta Pol. Pharm. Drug Res. 55:1998;389.
24. PALLAS for Windows 1.2, CompuDrug Chemistry Ltd., 1995.